| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rezolute, Inc. (RZLT) has 10 insiders with recent SEC Form 4 filings, including 22 buys and 0 sells. RZLT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 641.1K | $3.30M | - | |
| Other | 308.4K | $1.59M | - | |
| ? | 170.9K | $880.4K | - | |
| ? | 119.7K | $616.3K | - | |
| Other | 71.5K | $368.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2020 | Handok, Inc. | 10% Owner | Buy | 642,654 | $0.12 | $75,607.18 | +0.1% | |
| Jul 23, 2019 | Genexine Inc. | 10% Owner | Buy | 34,482,758 | $0.29 | $9,999,999.82 | +60.7% | |
| Jul 23, 2019 | Handok, Inc. | 10% Owner | Buy | 34,482,758 | $0.29 | $9,999,999.82 | +60.7% | |
| Mar 10, 2017 | Welch David F | Director | Buy | 15,000 | $0.96 | $14,400.00 | +0.3% | |
| Mar 6, 2017 | Welch David F | Director | Buy | 5,000 | $0.95 | $4,750.00 | +0.3% | |
| Feb 10, 2017 | Welch David F | Director | Buy | 5,000 | $0.99 | $4,950.00 | +21.6% | |
| Feb 9, 2017 | Welch David F | Director | Buy | 13,100 | $0.98 | $12,857.00 | +29.1% | |
| Feb 6, 2017 | Welch David F | Director | Buy | 10,000 | $0.96 | $9,550.00 | +200.0% | |
| Jan 20, 2017 | Welch David F | Director | Buy | 24,983 | $1.01 | $25,181.81 | +0.5% | |
| Jan 12, 2017 | Welch David F | Director | Buy | 5,000 | $0.95 | $4,750.00 | +50.0% |